Experienced in Pulmonary Vein Stenosis

Kai-helge R. Schmidt

Karlsruher Str. 84, 
Karlsruhe, BW, DE 
Experienced in Pulmonary Vein Stenosis
Karlsruher Str. 84, 
Karlsruhe, BW, DE 
OverviewLocationsClinical Research

Overview

Kai-helge Schmidt practices in Karlsruhe, Germany. Schmidt is rated as an Experienced expert by MediFind in the treatment of Pulmonary Vein Stenosis. Their top areas of expertise are Pulmonary Embolism, Pulmonary Hypertension, Hypertension, Stent Placement, and Transcatheter Aortic Valve Replacement (TAVR).

Their clinical research consists of co-authoring 24 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pulmonary Vein Stenosis.

Locations

Karlsruher Str. 84, Karlsruhe, BW 76139, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Safety and Efficacy of Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Intermediate-Risk Pulmonary Embolism
Safety and Efficacy of Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Intermediate-Risk Pulmonary Embolism
Enrollment Status: Terminated
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

24 Total Publications

Prevalence and significance of pulmonary hypertension among hospitalized patients with left heart disease.
Prevalence and significance of pulmonary hypertension among hospitalized patients with left heart disease.
Journal: Respiratory medicine
Published: June 06, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schmidt's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile